5XJ4 | Immune System | date | Apr 29, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Complex Structure Of Durvalumab-Scfvpd-L1 | ||||||||||||||
authors | S.Tan, K.Liu, Y.Chai, G.F.Gao, J.Qi | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Programmed Cell Death 1 Ligand 1 Chain: A Synonym: Programmed Death Ligand 1,B7 Homolog 1,B7-H1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Cd274, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Durvalumab-Vh Chain: H Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Durvalumab-Vl Chain: L Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 2 3 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 Å | ||||||||||||
Primary reference | Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab., Tan S, Liu K, Chai Y, Zhang CW, Gao S, Gao GF, Qi J, Protein Cell. 2018 Jan;9(1):135-139. doi: 10.1007/s13238-017-0412-8. PMID:28488247 |
Data retrieval |
View 5XJ4 in 3D |
Visual 3D analysis of 5XJ4 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5XJ4 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |